MARKET

MRK

MRK

Merck & Co
NYSE

Real-time Quotes | Nasdaq Last Sale

73.61
+0.56
+0.77%
After Hours: 73.73 +0.12 +0.16% 19:39 09/24 EDT
OPEN
73.59
PREV CLOSE
73.05
HIGH
74.63
LOW
73.35
VOLUME
14.71M
TURNOVER
--
52 WEEK HIGH
85.60
52 WEEK LOW
68.38
MARKET CAP
186.33B
P/E (TTM)
38.96
1D
5D
1M
3M
1Y
5Y
Oral vaccine Market Research Report with Key Drivers, Trends, and Opportunities by 2028
The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing companies' initiatives to enhance R&D, Newer and more expensive vaccines are coming into th...
Heraldkeepers · 19h ago
Why These 10 Stocks Are on the Move on Friday
In this article we will take a look at the some of notable stocks on the move today. You can skip our detailed analysis of these stocks and go to read Why These 5 Stocks Are on the Move on Friday. After yesterday’s big rally, the broader market is in the r...
Insider Monkey · 21h ago
Stocks making the biggest moves midday: Carnival, Nike, Match and more
These are the stocks posting the largest moves in midday trading.
CNBC.com · 22h ago
Why AstraZeneca Stock Is Trading Higher Today
AstraZeneca (NASDAQ: AZN) shares are trading higher after the company announced lynparza PROpel trial met the primary endpoint in metastatic castration-resistant prostate cancer.
Benzinga · 23h ago
Growth Hormone Deficiency Market: Industry Insights By Growth, Emerging Trends And Forecast By 2028
Research Nester published a report titled  which delivers a detailed overview of the growth hormone deficiency market in terms of market segmentation by application, by route of administration, by distribution channel,  and by region.
AmericaNewsHour · 23h ago
Organoids Market To Grow with a High CAGR Global Industry Analysis and Forecasts by 2027 | Impact of COVID-19 Pandemic
Research Nester released a report titled which delivers detailed overview of the global organoids market in terms of market segmentation by product, by application and by region.
AmericaNewsHour · 1d ago
BELLUS (BLU) Completes Enrollment in Two Mid-Stage Studies
Zacks.com · 1d ago
Sector Update: Health Care Stocks Retreat Friday
MT Newswires · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MRK. Analyze the recent business situations of Merck & Co through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 23 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MRK stock price target is 92.43 with a high estimate of 107.00 and a low estimate of 80.00.
EPS
Institutional Holdings
Institutions: 3.29K
Institutional Holdings: 2.00B
% Owned: 79.13%
Shares Outstanding: 2.53B
TypeInstitutionsShares
Increased
1.25K
101.06M
New
122
17.04M
Decreased
940
105.43M
Sold Out
113
4.63M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.45%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Chairman/Executive Director
Kenneth Frazier
President/Chief Executive Officer/Director
Robert Davis
Chief Financial Officer/Executive Vice President
Caroline Litchfield
Corporate Executive
Franklin Clyburn
Corporate Executive
Dean Li
Chief Human Resource Officer/Executive Vice President
Steven Mizell
Executive Vice President/General Counsel/Secretary
Jennifer Zachary
Executive Vice President
Sanat Chattopadhyay
Executive Vice President
Richard DeLuca
Executive Vice President
Julie Gerberding
Executive Vice President
Michael Klobuchar
Senior Vice President - Finance/Controller
Rita Karachun
Senior Vice President/Chief Compliance Officer
Michael Fleming
Other
Cristal Downing
Independent Director
Mary Coe
Independent Director
Pamela Craig
Independent Director
Thomas Glocer
Independent Director
Risa Lavizzo-Mourey
Independent Director
Stephen Mayo
Independent Director
Paul Rothman
Independent Director
Patricia Russo
Independent Director
Christine Seidman
Independent Director
Inge Thulin
Independent Director
Kathy Warden
Independent Director
Peter Wendell
Declaration Date
Dividend Per Share
Ex-Div Date
07/27/2021
Dividend USD 0.65
09/14/2021
05/25/2021
Dividend USD 0.65
06/14/2021
01/26/2021
Dividend USD 0.65
03/12/2021
11/17/2020
Dividend USD 0.65
12/14/2020
07/28/2020
Dividend USD 0.61
09/14/2020
05/26/2020
Dividend USD 0.61
06/12/2020
01/28/2020
Dividend USD 0.61
03/13/2020
11/19/2019
Dividend USD 0.61
12/13/2019
07/23/2019
Dividend USD 0.55
09/13/2019
05/28/2019
Dividend USD 0.55
06/14/2019
01/29/2019
Dividend USD 0.55
03/14/2019
10/25/2018
Dividend USD 0.55
12/14/2018
07/24/2018
Dividend USD 0.48
09/14/2018
05/22/2018
Dividend USD 0.48
06/14/2018
01/23/2018
Dividend USD 0.48
03/14/2018
11/28/2017
Dividend USD 0.48
12/14/2017
07/26/2017
Dividend USD 0.47
09/14/2017
05/23/2017
Dividend USD 0.47
06/13/2017
03/01/2017
Dividend USD 0.47
03/13/2017
11/22/2016
Dividend USD 0.47
12/13/2016
About MRK
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Webull offers kinds of Merck & Co., Inc. stock information, including NYSE:MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.